Notable Analyst Rating Changes 5/6: (ARIA) (MAC) (GM) Upgraded; (FRT) (WMB) (ZTS) Downgraded
Tweet Send to a Friend
UPGRADES
Cowen upgrades ARIAD Pharmaceuticals (Nasdaq: ARIA) from Market Perform to Outperform with a price target of $10.RBC Capital raises ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Cowen upgrades ARIAD Pharmaceuticals (Nasdaq: ARIA) from Market Perform to Outperform with a price target of $10.RBC Capital raises ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE